Pandemic-Linked Decline in Cancer Screening Persisted Into 2022
Low-dose computed tomographic scan rates and mammography rates below expected during March 2021 to February 2022.
Diagnosis & Disease Information
COVID-19-Related Treatment Delays, Discontinuations May Increase Disparities in Cancer Care
Race and ethnicity are associated with delays or discontinuations of cancer treatment after COVID-19, but social determinants of health are not, a study suggests.
Cancer Patients Have Higher Risk of Breakthrough COVID-19, Poor Outcomes
Patients with cancer have a higher risk of breakthrough SARS-CoV-2 infection and worse COVID-19 outcomes than patients without cancer.
Tixagevimab-Cilgavimab Effective Prophylaxis for COVID-19 in Immunocompromised, Vaccine Ineligible
This report explains the use of tixagevimab-cilgavimab as COVID-19 pre-exposure prophylaxis in patients who are immunocompromised or vaccine ineligible.
Risk of COVID-19 and Poor Outcomes Not Increased Among Glioma Patients
Patients with glioma do not have an increased risk of SARS-CoV-2 infection or worse outcomes from COVID-19, a single-center study suggests.
“Race Against Time” to Find Cancers Missed During COVID-19 Pandemic
The COVID-19 pandemic has hindered the early diagnosis and treatment of cancer, and this may have set back cancer outcomes by almost a decade in Europe, a new report suggests.
Patients, Clinicians Explain How the Pandemic Affected Genitourinary Cancer Care
A focus group sought to explore the effects of the changes in genitourinary cancer care during the COVID-19 pandemic from the perspective of patients and clinicians.
Cancer Therapy Deemed Safe for COVID-19 Patients Without Immunosuppression
In the absence of immunosuppression, systemic cancer therapies do not increase the risk of severe COVID-19 or cytokine storm, a study suggests.
Fewer Serious Adverse Events Reported in Cancer Trials During COVID-19 Pandemic
Serious adverse events were reported less frequently among patients enrolled in cancer trials during the first 2 years of the COVID-19 pandemic than among patients enrolled prior to the pandemic.
COVID-19 Is Still Causing Drug Shortages That Impact Cancer Care
Experts discuss current and potential future shortages affecting the oncology field as well as strategies for preventing and managing shortages.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...